Singapore-based Biorithm, a medtech startup focused on women’s health, has secured US$3.5 million in a series A round co-led by Adaptive Capital Partners and Seeds Capital to improve its pregnancy care solutions and remote monitoring operations.

Biorithm focuses on preventing pregnancy complications through its platform, which offers services like patient monitoring, personalized guidance, and analytics.